ASCE yields 0.21% · PFE yields 6.20%● Live data
📍 PFE pulled ahead of the other in Year 8
Combined, ASCE + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ASCE + PFE for your $10,000?
ASCE is actively managed and invests primarily in equity securities of small- and medium-cap US companies, within the Russell 2500 Index range. Up to 20% of total assets may be allocated to foreign issuers in developed markets, including ADRs. The fund combines quantitative methods with qualitative analysis in selecting companies believed to be relatively undervalued with possible future earnings. The quantitative method is based on a proprietary alpha model which ranks securities based on valuation, quality, and momentum. The qualitative analysis, on the other hand, includes management evaluation, products, competition, and risk. A focused portfolio of approximately 50 securities diversified across major sectors is curated, avoiding issuers with significant alcohol, gaming, or tobacco business. Cash or money market instruments may also be held for liquidity or short-term defensive investments, which may impact the funds objectives during such periods.
Full ASCE Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.